BMS CA116-003 FR
Application for participants in France Bristol Myers Squibb CA116-003 study.
Developer: Medable Inc.
App Size: Varies With Device
Release Date:
Price: Free
Medical
BMS CA116-003 FR
Screenshots for App
Mobile
You are invited to participate in the Bristol Myers Squibb CA116-003 study. This app is specifically intended to capture MORAb-202 (farletuzumab etceteribulin) reactions and symptoms. France participants only.
BMS CA116-003 FR 5.0.500.01-prod_france Update
2023-04-17 Version History
France participants only
~Medable Inc.
~Medable Inc.
More Information about: BMS CA116-003 FR
Price:
Free
Version:
5.0.500.01-prod_france
Downloads:
Compatibility:
Android 6.0
Bundle Id:
com.medable.bms.ca116003.fr
Size:
Varies With Device
Last Update:
2023-04-17
Content Rating:
Everyone
Release Date:
Content Rating:
Everyone
Developer:
Medable Inc.
Developer Apps
Latest Apps & Games
